CytomX Therapeutics Inc (NAS:CTMX)
$ 1.2 0 (0%) Market Cap: 93.74 Mil Enterprise Value: -31.70 Mil PE Ratio: 8.57 PB Ratio: 0 GF Score: 55/100

Q4 2023 CytomX Therapeutics Inc Earnings Call Transcript

Mar 11, 2024 / 09:00PM GMT
Release Date Price: $2.51 (+0.40%)
Operator

Good evening, and thank you for standing by, and welcome to the CytomX Therapeutics Fourth Quarter 2023 financial results conference call. At this time, all participants on a listen-only mode the speakers' presentation, there will be a question and answer session to ask a question. During the session, you will need to press star one on your telephone.

You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker for today, Chris Ogden, Senior Vice President, Finance and Accounting. Please go.

Chris Ogden
CytomX Therapeutics Inc - SVP, Finance and Accounting

Thank you. Good afternoon and thank you for joining us. Before we begin, I would like to remind everyone that during this call, we will be making forward-looking statements. Because forward-looking statements relate to the future. They are subject to inherent uncertainties and risks that are difficult to predict and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot